AstraZeneca to use new vax technology to treat cancer, heart disease
London, Sep 28 : UK drugmaker AstraZeneca has partnered with scientists at Imperial College London to develop a new vaccine technology to treat cancer, heart conditions and other non-infectious diseases and illnesses.The technology was originally int…